Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto J Montero

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Breast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.
Breast Cancer : Basic and Clinical Research|April 30, 2015
Defining the survival benchmark for breast cancer patients with systemic relapseSimon B Zeichner, Tadeu Ambros, John Zaravinos, et al.
Immunologic Research|November 13, 2013
Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62LC Marcela Díaz-Montero, Abdel-Aziz Zidan, Maria F Pallin, et al.
Clinical Breast Cancer|November 6, 2021
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 InhibitorsHanjie Mo, Catherine E Renna, Halle C F Moore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2025
Stakeholder perspectives on the role of caregivers in cancer clinical trial decision-making: results of a qualitative studyEric C Blackstone, Susan R Mazanec, Barbara J Daly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)Mohamed L Salem, C Marcela Díaz-Montero, Amir A Al-Khami, et al.
Breast Cancer Research and Treatment|June 22, 2016
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancerShruti R Tiwari, Prasun Mishra, Paola Raska, et al.
American Journal of Clinical Oncology|February 7, 2012
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancerPeter J Hosein, Gilberto de Lima Lopes, Vitor H Pastorini, et al.
Breast Cancer Research : BCR|June 20, 2026
Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancerNickolas Stabellini, Sonia D de Oliveira, Takae Mizukami, et al.
Journal of Translational Medicine|March 19, 2013
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumorsClaudia Marcela Diaz, Alberto Chiappori, Luigi Aurisicchio, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|July 29, 2017
Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centersCesar A Santa-Maria, Megan Kruse, Paola Raska, et al.
Breast Cancer : Basic and Clinical Research|April 30, 2015
Defining the survival benchmark for breast cancer patients with systemic relapseSimon B Zeichner, Tadeu Ambros, John Zaravinos, et al.
Immunologic Research|November 13, 2013
Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62LC Marcela Díaz-Montero, Abdel-Aziz Zidan, Maria F Pallin, et al.
Clinical Breast Cancer|November 6, 2021
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 InhibitorsHanjie Mo, Catherine E Renna, Halle C F Moore, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 10, 2025
Stakeholder perspectives on the role of caregivers in cancer clinical trial decision-making: results of a qualitative studyEric C Blackstone, Susan R Mazanec, Barbara J Daly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)Mohamed L Salem, C Marcela Díaz-Montero, Amir A Al-Khami, et al.
Breast Cancer Research and Treatment|June 22, 2016
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancerShruti R Tiwari, Prasun Mishra, Paola Raska, et al.
American Journal of Clinical Oncology|February 7, 2012
A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancerPeter J Hosein, Gilberto de Lima Lopes, Vitor H Pastorini, et al.
Breast Cancer Research : BCR|June 20, 2026
Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancerNickolas Stabellini, Sonia D de Oliveira, Takae Mizukami, et al.
Journal of Translational Medicine|March 19, 2013
Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumorsClaudia Marcela Diaz, Alberto Chiappori, Luigi Aurisicchio, et al.
Pageof 12